7210 Wareham Drive, Tampa, FL 33647
Nov. 17, 2025 Due to increased competition in the weight loss market and intense pressure from President Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients. This is is the latest step in the firm’s efforts to provide discounts to Americans willing to buy […]
Novo Nordisk Lowers Weight Loss Drug Prices Read More »
Sept. 12, 2025 According to an article by Food Navigator, the ketogenic diet, popular since the 1990s, is in decline, faced by consumer fatigue over restrictive requirements and strong competition from the GLP-1 medications. Analysts at Tastewise say that social mentions of keto dropped 18% by mid-year 2025 versus the prior year. Keto’s complex and
Keto Diet Is On The Decline Read More »
Sept. 3, 2025 WW announced the appointment of Alejandro Bethlen as Executive Vice President, International, effective immediately. In this role, Bethlen will oversee WeightWatchers’ business outside of the United States, driving international growth and innovation across the Company’s global footprint. “Alejandro’s international experience and commercial leadership make him uniquely suited to advance our growth outside
Weight Watchers Hires New International V.P. Read More »
November 20, 2024 Herbalife’s sales of weight management products in North America continue to decline, most likely due to strong competition from the GLP-1 weight loss drugs. Total U.S. sales for the 9 months ended Sept. 30, 2024 were down 7.9%, and North American sales represented 21% of the total. Total weight management sales from
Herbalife Weight Management Sales Continue Slide Read More »
June 13, 2024 Just 33% of employers and health plans cover the drugs for obesity, according to a report published Tuesday by consultant firm Pharmaceutical Strategies Group. The biggest reason? The drugs’ high costs. “Affordability is the main challenge, and we have seen a few employers offer coverage, then pull back after they evaluated the
Employers and Insurers Push Back on GLP-1 Drugs Coverage Read More »
Nov. 21, 2018 China’s leading one-stop healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited (“Ping An Good Doctor” ) today announced that it has entered into a strategic partnership with the Chinese Nutrition Society. Ping An Good Doctor will participate in the development of the first domestic “meal replacement food group standard” drafted by the
Chinese Joint Venture Explores Meal Replacements – Market Worth $750 Million Read More »